for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Australia's CSL reports 45% jump in half-year profit

Feb 18 (Reuters) - Australian biotech CSL Ltd on Thursday reported a 45% rise in half-year profit, boosted by higher demand for its vaccines and blood plasma products.

Net profit after tax came in at $1.81 billion for the six months ended December, up from $1.25 billion last year.

Reporting by Nikhil Kurian Nainan in Bengaluru; Editing by Bernard Orr

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up